You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞麗醫美(02135.HK)擬購面部植入物分銷商90%股權 代價9,500萬人幣
阿思達克 08-23 10:21
瑞麗醫美(02135.HK)公布,以9,500萬元人民幣(下同)收購深圳市九美信禾醫療器械合共90%股權的股本權益,當中2,500萬元以現金支付,其餘7,000萬元將由公司配發代價股支付,發行價每股0.477元。代價股份相當公司擴大後之已發行股份數目約7.78%。 深圳市九美信禾醫療器械為初真面部植入物(一家韓國進口的e-PTFE面部植入物品牌)的中國獨家分銷商。集團擬透過收購事項縱向拓展其於醫療美容服務行業的供應鏈並獲得更穩定及可靠的e-PTFE面部植入物,以促進業務運營的縱向整合,進而加強其收入來源。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account